Peptidakzeptorbindungsverfahren

Patent europeic · EP1870417 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1870417
Numer da la dumonda
EP07005917
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-07-2000
Publitgà
26-12-2007
Concedì
28-03-2012
Stritgà
18-07-2020
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 1/107 (2006.01)
C07K 17/02 (2006.01)
C12P 19/34 (2006.01)
C12N 15/11 (2006.01)
C12N 15/10 (2006.01)
Prioritad
US 145834 P 27.07.1999
Derivà da
EP00947524
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-07-2020

    Durada maximala cuntanschida

    Published in Swissreg on 20.07.2020

  2. 15-05-2012

    Represchentant inscrit

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 15.05.2012

  3. 28-03-2012

    Concedì

    Published in Swissreg on 28.03.2012

Partidas

Possessur

Bristol-Myers Squibb Company

Route 206 and Province Line Road, Princeton, NJ 08543-4000, US

Represchentant

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventur

Kurz, Markus

4054 Basel

Lohse, Peter

Weston, MA 02493, US

Wagner, Richard

Cambridge, MA 02138, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.